Inventor · disambiguated record
Yun-Ping Zhou
Also filed as: ZHOU YUN · ZHOU YUN-PING
9 granted patents·11 pending applications·62 citations·filing 2001–2022
85Inventor score
Top patents by PatentIndex Score
20 records- 0192US7928058B2Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the compositionMERCK SHARP & DOHME·Filed 2007·Granted Apr 19, 2011·37 cites·18 claims
- 0281US7087394B2Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRPMETABOLEX INC·Filed 2004·Granted Aug 8, 2006·18 cites·9 claims
- 0379US7344844B2Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)METABOLEX INC·Filed 2006·Granted Mar 18, 2008·1 cites·7 claims
- 0476US7144985B2Methods and reagents for diagnosis and treatment of diabetesMETABOLEX INC·Filed 2002·Granted Dec 5, 2006·3 cites·10 claims
- 0569US7109021B2Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)METABOLEX INC·Filed 2004·Granted Sep 19, 2006·1 cites·5 claims
- 0668USRE40624ECompositions and methods of using apoptosis signaling kinase related kinase (ASKRK)METABOLEX INC·Filed 2007·Granted Jan 20, 2009·0 cites·5 claims
- 0766US8268779B2Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the compositionSINHA ROY RANABIR·Filed 2011·Granted Sep 18, 2012·2 cites·14 claims
- 0863US2023088599A1Mir-149-3p and method for treating metabolic disease using the sameUNIV HENAN·Filed 2022·Application pending·0 cites
- 0962US7294698B2Methods and reagents for diagnosis and treatment of diabetesMETABOLEX INC·Filed 2006·Granted Nov 13, 2007·0 cites·1 claims
- 1060US2008248010A1Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)METABOLEX INC·Filed 2008·Application pending·0 cites
- 1158US2006234276A1Methods of treatment of type 2 diabetesPOLONSKY KENNETH S·Filed 2006·Application pending·0 cites
- 1252US2002150896A1Methods of treatment of type 2 diabetesUNIV TEXAS·Filed 2001·Application pending·0 cites
- 1351US2010143383A1Oxgr1 agonists for use in therapies for metabolic disordersHOWARD ANDREW D·Filed 2009·Application pending·0 cites
- 1451US2007031897A1Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRPMETABOLEX INC·Filed 2006·Application pending·0 cites
- 1550US2019153446A1Mir-149-3p and method for treating metabolic disease using the sameUNIV HENAN·Filed 2019·Application pending·0 cites
- 1649US2011123443A1Pancreatic beta-cell mass biomarkerMERCK & CO INC·Filed 2009·Application pending·0 cites
- 1749US2008064857A1Methods and Reagents for Diagnosis and Treatment of DiabetesMETABOLEX INC·Filed 2007·Application pending·0 cites
- 1848US2022414538A1Determining dynamic interaction condition(s) for triggering provision of related content interface notificationGOOGLE LLC·Filed 2019·Application pending·0 cites
- 1942US7879859B2Diagnosis and treatment of type 2 diabetes and other disordersMERCK SHARP & DOHME·Filed 2006·Granted Feb 1, 2011·0 cites·4 claims
- 2034US2012034608A1Microrna as a biomarker of pancreatic islet beta-cell engagementZHOU YUN-PING·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yun-Ping Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →